CI
BNTX icon

Cordant Inc’s BioNTech BNTX Stock Holding History

Cordant Inc’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$931 Buy
+10
New +$941 ﹤0.01% 154

Other funds holding BNTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
CCP
Crocodile Capital Partners Ursensollen, Germany $147M AUM 67.67% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return
S
Systrade Vaduz, Liechtenstein $160M AUM 73.26% 1-Year Est. Return
P
PensionDanmark Copenhagen O, Denmark $12B AUM
MC
Mirabaud & Cie Geneva, Switzerland $249M AUM 43.75% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
GIC
Generali Investments CEE Prague, Czech Republic $2.11B AUM 25.53% 1-Year Est. Return
GCM
Gallacher Capital Management Lone Tree, Colorado $178M AUM 29.29% 1-Year Est. Return

Cordant Inc's BNTX Position: Q2 2026 in Review

Cordant Inc opened a new position in BioNTech (BNTX) in Q2 2026: 10 shares worth $931. The stake represents ﹤0.01% of the portfolio and ranks #154 among its holdings.

18 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • Cordant Inc held 10 shares of BioNTech worth $931 as of Q2 2026.
  • BioNTech was a new Cordant Inc position in Q2 2026.
  • BioNTech made up ﹤0.01% of Cordant Inc's portfolio in Q2 2026, its #154 holding.
  • 18 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Cordant Inc's 13F filing for Q2 2026, filed 15 Jul 2026.